CMND · Clearmind Medicine Inc.
Market Cap
$2.63M
Shares
1.49M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Diluted EPS
-$303.50
+55.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| USD/shares | -$241.20 | -$303.50 | -$678.00 | -$17,030.40 | -$63,644.00 | -$35,264.00 |
| USD/shares | -$241.20 | -$303.50 | -$678.00 | -$17,030.40 | -$63,644.00 | -$35,264.00 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.